Literature DB >> 17673821

Paraneoplastic pemphigus associated with fludarabine use.

Ozcan Yildiz1, Mustafa Ozguroglu, M Teoman Yanmaz, Hande Turna, Sabiha Gokcen Kursunoglu, Meltem Antonov, Server Serdaroglu, Cuyan Demirkesen, Evin Buyukunal.   

Abstract

Paraneoplastic pemphigus is a severe mucocutaneous disease associated with B-cell lymphoproliferative disorders. A 51-yr-old man presented to the oncology clinic with mucocutaneous skin lesions after six cycles of fludarabine for non-Hodgkin's lymphoma. A punch biopsy from the skin showed suprabasal acantholysis and blister formation in the epidermis and upper dermis. Direct immunofluorescence demonstrated intercellular IgG deposition in all epidermal layers and complement (C3) at the basement membrane. The indirect immunofluorescence on rat bladder showed intercellular binding of IgG. These findings were consistent with paraneoplastic pemphigus associated with fludarabine use. The temporal association between fludarabine use and paraneoplastic pemphigus suggests there is an etiopathological link between these two entities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17673821     DOI: 10.1007/BF02685912

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  8 in total

Review 1.  [Auto-immune manifestations in Non-Hodgkin's lymphoma].

Authors:  F Jardin; H Lévesque; H Tilly
Journal:  Rev Med Interne       Date:  2004-12-18       Impact factor: 0.728

2.  Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine.

Authors:  A Bazarbachi; H Bachelez; L Dehen; A Delmer; R Zittoun; L Dubertret
Journal:  Ann Oncol       Date:  1995-09       Impact factor: 32.976

3.  Graft-versus-host disease-like immunophenotype and apoptotic keratinocyte death in paraneoplastic pemphigus.

Authors:  K Reich; U Brinck; M Letschert; V Blaschke; K Dames; J Braess; B Wörmann; T M Rünger; C Neumann
Journal:  Br J Dermatol       Date:  1999-10       Impact factor: 9.302

4.  Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.

Authors:  Z T Maung; A C Wood; G H Jackson; G E Turner; A L Appleton; P J Hamilton
Journal:  Br J Haematol       Date:  1994-11       Impact factor: 6.998

5.  Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.

Authors:  G J Anhalt; S C Kim; J R Stanley; N J Korman; D A Jabs; M Kory; H Izumi; H Ratrie; D Mutasim; L Ariss-Abdo
Journal:  N Engl J Med       Date:  1990-12-20       Impact factor: 91.245

6.  Paraneoplastic pemphigus: an association with fludarabine?

Authors:  C Gooptu; T J Littlewood; P Frith; C C Lyon; A J Carmichael; S Oliwiecki; A MacWhannell; M Amagai; T Hashimoto; D Dean; J Allen; F Wojnarowska
Journal:  Br J Dermatol       Date:  2001-06       Impact factor: 9.302

7.  [Paraneoplastic bullous dermatoses].

Authors:  G A Panteleeva
Journal:  Vestn Dermatol Venerol       Date:  1990

8.  Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.

Authors:  S O'Brien; H Kantarjian; M Beran; T Smith; C Koller; E Estey; L E Robertson; S Lerner; M Keating
Journal:  Blood       Date:  1993-09-15       Impact factor: 22.113

  8 in total
  3 in total

Review 1.  [Paraneoplastic autoimmune dermatoses].

Authors:  D Didona; M Hertl
Journal:  Hautarzt       Date:  2021-03-01       Impact factor: 0.751

2.  Ocular toxicity of fludarabine: a purine analog.

Authors:  Xiaoyan Ding; Alexandra A Herzlich; Rachel Bishop; Jingsheng Tuo; Chi-Chao Chan
Journal:  Expert Rev Ophthalmol       Date:  2008-02

3.  Small lymphocytic lymphoma with florid perniosis-like features: a case report.

Authors:  Taylor M Morris; Rosetta Mazzola; Brian Berry; Douglas Sawyer; David L Saltman
Journal:  BMC Dermatol       Date:  2015-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.